TAKEDA PHARMA A/S: Financial statements 2017
CVR: 16406899
Source: annual report 2017, Danish Business Authority
01/04/2016 – 31/03/2017
TAKEDA PHARMA A/S (CVR 16406899) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 1,728,098,000 and a net result of DKK -102,646,000 compared with DKK 25,296,957,000 the year before. That is an increase of 2.7% compared with the year before. The profit margin was -5.9%. Equity in the 2017 report amounted to DKK 99,939,154,000. The solvency ratio was 99.6%. The company had 305 employees in the financial year.
- Revenue
- DKK 1,728,098,000
- Gross Profit
- DKK 625,966,000
- Profit/Loss
- DKK -102,646,000
- Equity
- DKK 99,939,154,000
- Total Assets
- DKK 100,387,006,000
- Employees
- 305
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 1.7 mia. | 626 mio. | -102.6 mio. | 99.9 mia. | 305 |
| 2016 | 1.7 mia. | 212.5 mio. | 25.3 mia. | 100.2 mia. | 488 |
Official annual report
Keep an eye on TAKEDA PHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of December 20, 2017, Athinagoras Efthymios Giannoulis has joined the board of directors of TAKEDA PHARMA A/S.
As of December 20, 2017, Ghita Astrup has left the board of directors of TAKEDA PHARMA A/S.
As of November 20, 2017, Lars Patrik Mikael Forsell is registered as adm. dir. of TAKEDA PHARMA A/S.
As of November 20, 2017, Christian Ramskov has stepped down as adm. dir. of TAKEDA PHARMA A/S.
As of October 1, 2017, Christian Ramskov is registered as adm. dir. of TAKEDA PHARMA A/S.
As of September 30, 2017, Ghita Astrup has stepped down as adm. dir. of TAKEDA PHARMA A/S.
As of August 16, 2017, Marianne Jacobsen has left the board of directors of TAKEDA PHARMA A/S.
As of May 11, 2017, Ingeborg Rossebø Borgheim has joined the board of directors of TAKEDA PHARMA A/S.
As of May 11, 2017, Jean Luc Delay has left the board of directors of TAKEDA PHARMA A/S.
About TAKEDA PHARMA A/S
TAKEDA PHARMA A/S is a Danish company of the type Aktieselskab based in Vallensbæk Strand, founded in 1984. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named NYCOMED DANMARK ApS and NYCOMED DANMARK A/S. The management consists of Enor Cerimagic. The board consists of Koki Sato (chair), Enor Cerimagic, Jesper Lindahl and Malene Kelstrup. The company is owned by Takeda Pharmaceuticals International AG. The company has 79 employees (2026). In 2026, the company reported revenue of DKK 1,112,753,000 and a net result of DKK 88,641,000 compared with DKK 12,162,000 the year before. Equity in the 2026 report amounted to DKK 456,501,000.